- Home
- LFT vs INO Comparison
LFT vs INO Comparison
Compare LFT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFT
- INO
- Stock Information
- Founded
- LFT 2012
- INO 1979
- Country
- LFT United States
- INO United States
- Employees
- LFT N/A
- INO N/A
- Industry
- LFT Real Estate Investment Trusts
- INO Medical/Dental Instruments
- Sector
- LFT Real Estate
- INO Health Care
- Exchange
- LFT Nasdaq
- INO Nasdaq
- Market Cap
- LFT 127.0M
- INO 110.7M
- IPO Year
- LFT N/A
- INO 1998
- Fundamental
- Price
- LFT $2.54
- INO $4.18
- Analyst Decision
- LFT Buy
- INO Buy
- Analyst Count
- LFT 3
- INO 6
- Target Price
- LFT $2.50
- INO $16.33
- AVG Volume (30 Days)
- LFT 78.2K
- INO 359.2K
- Earning Date
- LFT 11-12-2024
- INO 11-14-2024
- Dividend Yield
- LFT 12.45%
- INO N/A
- EPS Growth
- LFT 52.57
- INO N/A
- EPS
- LFT 0.35
- INO N/A
- Revenue
- LFT $36,400,239.00
- INO $203,413.00
- Revenue This Year
- LFT N/A
- INO N/A
- Revenue Next Year
- LFT N/A
- INO N/A
- P/E Ratio
- LFT $7.41
- INO N/A
- Revenue Growth
- LFT 25.86
- INO N/A
- 52 Week Low
- LFT $2.01
- INO $3.85
- 52 Week High
- LFT $2.75
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- LFT 50.76
- INO 19.02
- Support Level
- LFT $2.32
- INO $3.85
- Resistance Level
- LFT $2.50
- INO $5.60
- Average True Range (ATR)
- LFT 0.10
- INO 0.28
- MACD
- LFT 0.01
- INO -0.13
- Stochastic Oscillator
- LFT 69.18
- INO 6.67
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.